SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 2/26/19 Omega Healthcare Investors Inc 10-K 12/31/18 157:34M OHI Healthcare Properties Limited Partnership |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 3.00M 2: EX-10.8A Material Contract HTML 75K 3: EX-10.8B Material Contract HTML 90K 4: EX-10.8C Material Contract HTML 82K 5: EX-10.8D Material Contract HTML 103K 6: EX-10.8E Material Contract HTML 82K 7: EX-10.8F Material Contract HTML 102K 8: EX-21 Subsidiaries List HTML 383K 9: EX-23.1 Consent of Experts or Counsel HTML 41K 10: EX-23.2 Consent of Experts or Counsel HTML 41K 11: EX-31.1 Certification -- §302 - SOA'02 HTML 45K 12: EX-31.2 Certification -- §302 - SOA'02 HTML 45K 13: EX-31.3 Certification -- §302 - SOA'02 HTML 45K 14: EX-31.4 Certification -- §302 - SOA'02 HTML 45K 15: EX-32.1 Certification -- §906 - SOA'02 HTML 41K 16: EX-32.2 Certification -- §906 - SOA'02 HTML 40K 17: EX-32.3 Certification -- §906 - SOA'02 HTML 41K 18: EX-32.4 Certification -- §906 - SOA'02 HTML 41K 25: R1 Document and Entity Information HTML 77K 26: R2 Consolidated Balance Sheets HTML 160K 27: R3 Consolidated Balance Sheets (Parentheticals) HTML 46K 28: R4 Consolidated Statements of Operations HTML 173K 29: R5 Consolidated Statements of Comprehensive Income HTML 68K 30: R6 Consolidated Statements of Changes in Equity HTML 151K 31: R7 Consolidated Statements of Changes in Equity HTML 81K (Parentheticals) 32: R8 Consolidated Statements of Changes in Owners' HTML 100K Equity 33: R9 Consolidated Statements of Cash Flows HTML 197K 34: R10 Organization and Basis of Presentation HTML 46K 35: R11 Summary of Significant Accounting Policies HTML 140K 36: R12 Properties HTML 464K 37: R13 Direct Financing Leases HTML 122K 38: R14 Mortgage Notes Receivable HTML 72K 39: R15 Other Investments HTML 97K 40: R16 Variable Interest Entities HTML 127K 41: R17 Investment in Unconsolidated Joint Venture HTML 41K 42: R18 Assets Held for Sale HTML 69K 43: R19 Intangibles HTML 89K 44: R20 Concentration of Risk HTML 41K 45: R21 Lease and Mortgage Deposits HTML 40K 46: R22 Borrowing Arrangements HTML 259K 47: R23 Financial Instruments HTML 157K 48: R24 Taxes HTML 82K 49: R25 Retirement Arrangements HTML 40K 50: R26 Stockholders'/Owners' Equity HTML 127K 51: R27 Stock-Based Compensation HTML 416K 52: R28 Dividends HTML 83K 53: R29 Commitments and Contingencies HTML 62K 54: R30 Supplemental Disclosure to Consolidated Statements HTML 141K of Cash Flows 55: R31 Summary of Quarterly Results (Unaudited) HTML 214K 56: R32 Earnings Per Share/Unit HTML 163K 57: R33 Subsequent Events HTML 41K 58: R34 Schedule Ii - Valuation and Qualifying Accounts HTML 163K 59: R35 Schedule Iii - Real Estate and Accumulated HTML 1.40M Depreciation 60: R36 Schedule Iv - Mortgage Loans on Real Estate HTML 309K 61: R37 Summary of Significant Accounting Policies HTML 223K (Policies) 62: R38 Summary of Significant Accounting Policies HTML 60K (Tables) 63: R39 Properties (Tables) HTML 458K 64: R40 Direct Financing Leases (Tables) HTML 111K 65: R41 Mortgage Notes Receivable (Tables) HTML 67K 66: R42 Other Investments (Tables) HTML 78K 67: R43 Variable Interest Entities (Tables) HTML 131K 68: R44 Assets Held for Sale (Tables) HTML 70K 69: R45 Intangibles (Tables) HTML 91K 70: R46 Borrowing Arrangements (Tables) HTML 239K 71: R47 Financial Instruments (Tables) HTML 149K 72: R48 Taxes (Tables) HTML 71K 73: R49 Stockholders'/Owners' Equity (Tables) HTML 122K 74: R50 Stock-Based Compensation (Tables) HTML 416K 75: R51 Dividends (Tables) HTML 85K 76: R52 Commitments and Contingencies (Tables) HTML 50K 77: R53 Supplemental Disclosure to Consolidated Statements HTML 140K of Cash Flows (Tables) 78: R54 Summary of Quarterly Results (Unaudited) (Tables) HTML 213K 79: R55 Earnings Per Share/Unit (Tables) HTML 164K 80: R56 Organization and Basis of Presentation (Details) HTML 45K 81: R57 Summary of Significant Accounting Policies HTML 52K (Narrative) (Detail) 82: R58 Summary of Significant Accounting Policies HTML 153K (Narrative 2) (Detail) 83: R59 Summary of Significant Accounting Policies HTML 56K (Accounts Receivable) (Detail) 84: R60 PROPERTIES - Leased Property (Narrative) (Detail) HTML 67K 85: R61 PROPERTIES - Summary of our investment in leased HTML 59K real estate properties (Details) 86: R62 PROPERTIES - Future minimum estimated contractual HTML 57K rents due (Detail) 87: R63 PROPERTIES - 2018 Acquisitions and Other (Detail) HTML 185K 88: R64 PROPERTIES - 2018 Acquisitions and Other HTML 103K (Narrative) (Detail) 89: R65 PROPERTIES - 2017 Acquisitions and Other (Detail) HTML 155K 90: R66 PROPERTIES - 2016 Acquisitions and Other (Detail) HTML 235K 91: R67 PROPERTIES - 2016 Acquisitions and Other HTML 106K (Narrative) (Detail) 92: R68 PROPERTIES - Assets Sold or Held for Sale HTML 158K (Narrative) (Detail) 93: R69 Direct Financing Leases (Narrative) (Detail) HTML 56K 94: R70 Direct Financing Leases (Narrative 1) (Detail) HTML 48K 95: R71 Direct Financing Leases (Narrative 2) (Detail) HTML 49K 96: R72 Direct Financing Leases (Narrative 3) (Detail) HTML 218K 97: R73 Mortgage Notes Receivable (Narrative) (Detail) HTML 47K 98: R74 Mortgage Notes Receivable (Schedule of HTML 76K Receivables) (Detail) 99: R75 Mortgage Notes Receivable (Notes Due 2027 HTML 58K Narrative) (Detail) 100: R76 Mortgage Notes Receivable (Notes Due 2029 HTML 94K Narrative) (Detail) 101: R77 Mortgage Notes Receivable (Notes Paid Off HTML 47K Narrative) (Detail) 102: R78 Other Investments (Schedule of Receivables) HTML 75K (Details) 103: R79 Other Investments (Note Due 2018-2022 Narrative) HTML 72K (Detail) 104: R80 Other Investments (Note Due 2019 Narrative) HTML 62K (Detail) 105: R81 Other Investments (Note Due 2020 Narrative) HTML 80K (Detail) 106: R82 Other Investments (Note Due 2023 Narrative) HTML 73K (Detail) 107: R83 Other Investments (Note Due 2024-2025 Narrative) HTML 66K (Detail) 108: R84 Variable Interest Entities (Detail) HTML 95K 109: R85 Investment in Unconsolidated Joint Venture HTML 73K (Narrative) (Details) 110: R86 Assets Held for Sale (Detail) HTML 50K 111: R87 Assets Held for Sale (Narrative) (Detail) HTML 66K 112: R88 INTANGIBLES - Summary of our intangibles (Detail) HTML 58K 113: R89 Intangibles (Narrative) (Detail) HTML 50K 114: R90 Intangibles (Narrative 2) (Detail) HTML 38K 115: R91 Intangibles - Reconciliation of goodwill (Detail) HTML 42K 116: R92 Concentration of Risk (Narrative) (Detail) HTML 102K 117: R93 Lease and Mortgage Deposits (Narrative) (Detail) HTML 51K 118: R94 Borrowing Arrangements (Details) HTML 191K 119: R95 Borrowing Arrangements (Narrative) (Detail) HTML 70K 120: R96 Borrowing Arrangements (Narrative 1) (Detail) HTML 129K 121: R97 Borrowing Arrangements (Narrative 2) (Detail) HTML 67K 122: R98 Borrowing Arrangements (Narrative 3) (Detail) HTML 98K 123: R99 Borrowing Arrangements - Principal payments HTML 56K (Detail) 124: R100 BORROWING ARRANGEMENTS - Refinancing related costs HTML 44K (Details) 125: R101 BORROWING ARRANGEMENTS - Refinancing related costs HTML 68K (Narrative) (Detail) 126: R102 Financial Instruments (Details) HTML 94K 127: R103 Financial Instruments (Narrative) (Detail) HTML 57K 128: R104 Taxes (Narrative) (Detail) HTML 96K 129: R105 Taxes (Detail) HTML 57K 130: R106 Retirement Arrangements (Narrative) (Detail) HTML 43K 131: R107 Stockholders'/Owners' Equity (Narrative) (Details) HTML 52K 132: R108 Stockholders'/Owners' Equity (Narrative 2) HTML 44K (Detail) 133: R109 Stockholders'/Owners' Equity (Details) HTML 98K 134: R110 Stock-Based Compensation (Detail) HTML 70K 135: R111 Stock-Based Compensation (Narrative) (Detail) HTML 59K 136: R112 Stock-Based Compensation (1) (Detail) HTML 61K 137: R113 Stock-Based Compensation (2) (Detail) HTML 75K 138: R114 Stock-Based Compensation (3) (Detail) HTML 105K 139: R115 Dividends (Details) HTML 56K 140: R116 Dividends (Per Share Distributions) (Detail) HTML 46K 141: R117 Commitments and Contingencies (Narrative) HTML 69K (Details) 142: R118 Commitments and Contingencies (Detail) HTML 43K 143: R119 Supplemental Disclosure to Consolidated Statements HTML 88K of Cash Flows (Detail) 144: R120 Summary of Quarterly Results (Unaudited) (Detail) HTML 84K 145: R121 Summary of Quarterly Results (Unaudited) HTML 44K (Narrative) (Detail) 146: R122 EARNINGS PER SHARE/UNIT - Computation of basic and HTML 107K diluted earnings per share (Detail) 147: R123 Subsequent Events (Narrative) (Detail) HTML 66K 148: R124 Schedule Ii - Valuation and Qualifying Accounts HTML 59K (Detail) 149: R125 Schedule Iii - Real Estate and Accumulated HTML 665K Depreciation (Detail) 150: R126 Schedule Iii - Real Estate and Accumulated HTML 61K Depreciation (Narrative) (Detail) 151: R127 Schedule Iii - Real Estate and Accumulated HTML 41K Depreciation (Narrative 1) (Detail) 152: R128 Schedule Iv - Mortgage Loans on Real Estate HTML 137K (Detail) 153: R129 Schedule Iv - Mortgage Loans on Real Estate HTML 54K (Narrative 1) (Detail) 154: R130 Schedule Iv - Mortgage Loans on Real Estate HTML 41K (Narrative 2) (Detail) 156: XML IDEA XML File -- Filing Summary XML 283K 155: EXCEL IDEA Workbook of Financial Reports XLSX 226K 19: EX-101.INS XBRL Instance -- ohi-20181231 XML 10.32M 21: EX-101.CAL XBRL Calculations -- ohi-20181231_cal XML 291K 22: EX-101.DEF XBRL Definitions -- ohi-20181231_def XML 1.92M 23: EX-101.LAB XBRL Labels -- ohi-20181231_lab XML 2.60M 24: EX-101.PRE XBRL Presentations -- ohi-20181231_pre XML 2.52M 20: EX-101.SCH XBRL Schema -- ohi-20181231 XSD 438K 157: ZIP XBRL Zipped Folder -- 0000888491-19-000006-xbrl Zip 486K
ohi_Ex10_8F |
Exhibit 10.8F
RELATIVE TSR-BASED PERFORMANCE PROFITS INTEREST UNITS AGREEMENT PURSUANT TO THE OMEGA HEALTHCARE INVESTORS, INC.
2018 STOCK INCENTIVE PLAN
The grant pursuant to this agreement (this “Agreement”) is made as of the Grant Date, by OHI Healthcare Properties Limited Partnership (the “Partnership”), a limited partnership controlled by, and an Affiliate (as defined below) of, Omega Healthcare Investors, Inc. (Omega Healthcare Investors, Inc. is hereafter referred to as the “Company”), to _____________________ (the “Recipient”).
Upon and subject to this Agreement (which shall include the Terms and Conditions and Exhibits appended to the execution page) and the Limited Partnership Agreement (as defined herein), the Partnership hereby awards as of the Grant Date to the Recipient the number of Profits Interest Units set forth below (the “Profits Interest Unit Grant” or the “Award”). The underlined and capitalized captions in Items A through E below shall have the meanings therein ascribed to them.
A. Grant Date: _________, 20__.
B. Plan (under which Profits Interest Unit Grant is granted): Omega Healthcare Investors, Inc. 2018 Stock Incentive Plan.
C. Profits Interest Units: _______ Profits Interest Units. “Profits Interest Units” has the same meaning as “LTIP Units” as defined in the Limited Partnership Agreement, and each Profits Interest Unit represents, on the Grant Date, one “Unvested Profits Interest Unit,” which is one “Unvested LTIP Unit” as defined in and pursuant to the Limited Partnership Agreement, subject to adjustment as provided in the attached Terms and Conditions, and also represents the Partnership’s unsecured obligation to issue to the Recipient distributions described in Item E below.
D. Vesting of LTIP Units: The Recipient shall become vested in a number of Profits Interest Units (“Vested Profits Interest Units”) as and when determined pursuant to Exhibit 1.
E. Distributions: The “LTIP Unit Distributions Participation Date” attributable to Profits Interest Units as defined in and pursuant to Section 15.4 of the Limited Partnership Agreement shall be __________, 20__; provided, however, that until any of the Profits Interest Units become “Earned Unvested Profits Interest Units” the Recipient shall receive a distribution when paid to holders of “LP Units” (as defined in the Limited Partnership Agreement) of an amount per Profits Interest Unit (the “Interim Distribution per Profits Interest Unit”), and an allocation of “Net Income and Net Loss” (as defined in the Limited Partnership Agreement) per Profits Interest Unit, equal to (i) 10% of the regular periodic distributions per LP Unit paid by the Partnership to LP Unit holders and a corresponding percentage allocation of Net Income and Net Loss attributable to the regular periodic distributions per LP Unit and (ii) 0% of the special distributions and other distributions not made in the ordinary
course per LP Unit paid by the Partnership to LP Unit holders and a corresponding 0% allocation of Net Income and Net Loss attributable to the special distributions and other distributions per LP Unit not made in the ordinary course. As to all Profits Interest Units that become Earned Unvested Profits Interest Units, the Recipient shall receive within twenty (20) business days after the date they become Earned Unvested Profits Interest Units, a distribution from the Partnership per Earned Unvested Profits Interest Unit and a corresponding allocation of Net Income and Net Loss per Earned Unvested Profits Interest Unit equal to the excess of (x) the amount of distributions from the Partnership that would have been paid per Profits Interest Unit if the Profits Interest Unit had been an LP Unit on _________, 20__ (determined without regard to this Item E) over (y) the Interim Distribution per Profits Interest Unit. In addition, with respect to distributions and allocations of Net Income and Net Loss that accrue following the date that any Profits Interest Units become Earned Unvested Profits Interest Units or Vested Profits Interest Units, the Recipient shall receive with respect to each Earned Unvested Profits Interest Unit and each Vested Profits Interest Unit distributions and allocations of Net Income and Net Loss pursuant to the Limited Partnership Agreement determined without regard to the adjustments in this Item E.
2
IN WITNESS WHEREOF, the Partnership and the Recipient have executed and agree to be bound by this Agreement effective as of the Grant Date set forth above.
|
OHI HEALTHCARE PROPERTIES LIMITED PARTNERSHIP |
|
|
|
|
|
|
|
|
By: |
|
|
|
|
|
Title: |
|
|
|
|
|
|
|
|
RECIPIENT |
|
|
|
|
|
By: |
|
3
TERMS AND CONDITIONS TO THE
RELATIVE TSR-BASED PERFORMANCE PROFITS INTEREST UNITS AGREEMENT PURSUANT TO THE OMEGA HEALTHCARE INVESTORS, INC.
2018 STOCK INCENTIVE PLAN
1. Conditions to Grant of Profits Interest Units. As a condition of receiving the grant of Profits Interest Units hereunder, the Recipient must (a) execute the representations and warranties set forth on Exhibit 2 attached hereto, and deliver them to the Partnership within ten (10) days of the Grant Date, and (b) file with the IRS within thirty (30) days of the Grant Date, a valid election under Code Section 83(b), in substantially the form of Exhibit 3 attached hereto, as to all of the Profits Interest Units. The Recipient must also deliver to the Partnership, within thirty (30) days after the Grant Date, a copy of such election. Failure to comply with the requirements of this Section shall result in the forfeiture of all the Profits Interest Units and the cancellation of this Agreement.
2. Issuance of Profits Interest Units. The Partnership shall record in the name of the Recipient the number of Profits Interest Units (“LTIP Units,” as defined in the Limited Partnership Agreement”) awarded as of the Grant Date. The Partnership and the Recipient acknowledge and agree that the Profits Interest Units are hereby issued to the Recipient for the performance of services to or for the benefit of the Partnership and its Affiliates. If the Recipient is not already a partner of the Partnership pursuant to the Limited Partnership Agreement (defined therein as a “Partner”), the Partnership admits the Recipient as an “LTIP Unit Limited Partner” (as defined therein) and a Partner on the terms and conditions in this Agreement, the Plan and the Limited Partnership Agreement. Upon execution of this Agreement, the Recipient shall, automatically and without further action on the Recipient’s part, be deemed to be a signatory of and bound by the Limited Partnership Agreement. At the request of the Partnership, the Recipient shall execute the Limited Partnership Agreement or a counterpart signature page thereto.
3. Rights as a Unitholder. The Profits Interest Units shall be treated as a “profits interest” within the meaning of Revenue Procedure 93-27, and the Recipient shall be treated as having received the interest on the Grant Date as contemplated under Section 4 of Revenue Procedure 2001-43. As the owner of the Profits Interest Units for income tax purposes, the Recipient shall take into account the Recipient’s distributive share of income, gain, loss, deduction and credit associated with the Profits Interest Units as determined in accordance with the terms of the Limited Partnership Agreement and this Agreement.
4. Restrictions on Transfer. The Recipient shall not sell, pledge, assign, transfer or hypothecate, or otherwise dispose of any Profits Interest Units, whether outright or as security, with or without consideration, voluntary or involuntary, of all or any part of any right, title or interest in or to the Profits Interest Units, except as otherwise provided in the Limited Partnership Agreement. Any disposition not made in accordance with this Agreement shall be deemed null and void. Any permitted transferee under this Section shall be bound by the terms of this Agreement and the Limited Partnership Agreement.
5. Tax Withholding. If and only if tax withholding applies with respect to the grant, vesting, ownership or disposition of Profits Interest Units, the Company or an Affiliate may
4
withhold from the Recipient’s wages, or require the Recipient to remit to the Partnership, the Company or an Affiliate, any applicable required tax withholding.
6. Change in Capitalization.
(a) The number and kind of units issuable under this Agreement shall be proportionately adjusted for any non-reciprocal transaction between the Partnership and the holders of partnership interests of the Partnership that causes the per unit value of the Profits Interest Units subject to the Award to change, such as a stock dividend, stock split, spinoff, rights offering, or recapitalization through a large, non-recurring cash dividend (each, an “Equity Restructuring”). No fractional shares shall be issued in making such adjustment.
(b) In the event of a merger, consolidation, reorganization, extraordinary dividend, sale of substantially all of the Partnership’s assets, other material change in the capital structure of the Partnership, or a tender offer for Profits Interest Units (“LTIP Units,” as defined in the Limited Partnership Agreement), in each case that does not constitute an Equity Restructuring, the Committee shall take such action to make such adjustments with respect to the Profits Interest Units hereunder or the terms of this Agreement as the Committee, in its sole discretion, determines in good faith is necessary or appropriate, including, without limitation, adjusting the number and class of securities subject to the Award, substituting cash, other securities, or other property to replace the Award, or removing of restrictions.
(c) All determinations and adjustments made by the Committee pursuant to this Section will be final and binding on the Recipient. Any action taken by the Committee need not treat all recipients of awards under the Plan equally.
(d) The existence of the Plan and the Profits Interest Unit Grant shall not affect the right or power of the Partnership to make or authorize any adjustment, reclassification, reorganization or other change in its capital or business structure, any merger or consolidation of the Partnership, any issue of debt or equity securities having preferences or priorities as to the Profits Interest Units or the rights thereof, the dissolution or liquidation of the Partnership, any sale or transfer of all or part of its business or assets, or any other corporate act or proceeding.
7. Governing Laws. This Award shall be construed, administered and enforced according to the laws of the State of Maryland; provided, however, no Profits Interest Units shall be issued except, in the reasonable judgment of the Committee, in compliance with exemptions under applicable state securities laws of the state in which Recipient resides, and/or any other applicable securities laws.
8. Successors. This Agreement shall be binding upon and inure to the benefit of the heirs, legal representatives, successors, and permitted assigns of the parties.
9. Notice. Except as otherwise specified herein, all notices and other communications under this Agreement shall be in writing and shall be deemed to have been given if personally delivered or if sent by registered or certified United States mail, return receipt
5
requested, postage prepaid, addressed to the proposed recipient at the last known address of the recipient. Any party may designate any other address to which notices shall be sent by giving notice of the address to the other parties in the same manner as provided herein.
10. Severability. In the event that any one or more of the provisions or portion thereof contained in this Agreement shall for any reason be held to be invalid, illegal, or unenforceable in any respect, the same shall not invalidate or otherwise affect any other provisions of this Agreement, and this Agreement shall be construed as if the invalid, illegal or unenforceable provision or portion thereof had never been contained herein.
11. Entire Agreement. This Agreement and the Limited Partnership Agreement, together with the terms and conditions set forth in the Plan, express the entire understanding and agreement of the parties with respect to the subject matter. In the event of a conflict between the terms of the Plan or the Limited Partnership Agreement and this Agreement, the Plan and the Limited Partnership Agreement shall govern.
12. Specific Performance. In the event of any actual or threatened default in, or breach of, any of the terms, conditions and provisions of this Agreement, the party or parties who are thereby aggrieved shall have the right to specific performance and injunction in addition to any and all other rights and remedies at law or in equity, and all such rights and remedies shall be cumulative.
13. No Right to Continued Retention. Neither the establishment of the Plan nor the Award hereunder shall be construed as giving Recipient the right to continued service with the Company or an Affiliate.
14. Tax Effects under 409A. It is intended that the Award under this Agreement be exempt from Section 409A of the Internal Revenue Code (the “Code”) as a current grant of a profits interest as provided in Section 3 hereof.
15. Headings and Capitalized Terms. Except as otherwise provided in this Agreement, section headings used herein are for convenience of reference only and shall not be considered in construing this Agreement. Capitalized terms used, but not defined, in this Agreement shall be given the meaning ascribed to them in the Plan.
16. Definitions. As used in this Agreement:
“Beginning Stock Price” means the average closing price per share of Common Stock for the months of November and December 20__ on the exchange on which Common Stock is traded, which is $__.__.
“Below Threshold Relative TSR” means that Relative Total Shareholder Return is less than ____ basis points.
6
“Cause” shall have the meaning set forth in the employment agreement then in effect between the Recipient and the Company or an Affiliate, or, if there is none, then Cause shall mean the occurrence of any of the following events:
(a) willful refusal by the Recipient to follow a lawful direction of the person to whom the Recipient reports or the Board of Directors of the Company (the “Board”), provided the direction is not materially inconsistent with the duties or responsibilities of the Recipient’s position with the Company or an Affiliate, which refusal continues after the Board has again given the direction in writing;
(b) willful misconduct or reckless disregard by the Recipient of the Recipient’s duties or with respect to the interest or material property of the Company or an Affiliate;
(c) material breach by the Recipient of the Intellectual Property Agreement between the Recipient and the Company, which causes material harm to the Company or an Affiliate;
(d) any act by the Recipient of fraud against, material misappropriation from or significant dishonesty to either the Company or an Affiliate, or any other party, but in the latter case only if in the reasonable opinion of at least two-thirds of the members of the Board (excluding the Recipient), such fraud, material misappropriation, or significant dishonesty could reasonably be expected to have a material adverse impact on the Company or its Affiliates; or
(e) commission by the Recipient of a felony as reasonably determined by at least two-thirds of the members of the Board (excluding the Recipient).
“Change in Control” means any one of the following events which occurs following the Grant Date:
(a) the acquisition within a twelve (12) month period, directly or indirectly, by any “person” or “persons” (as such terms are used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended), other than the Company or any employee benefit plan of the Company or an Affiliate, or any corporation pursuant to a reorganization, merger or consolidation, of equity securities of the Company that in the aggregate represent thirty percent (30%) or more of the total voting power of the Company’s then outstanding equity securities;
(b) the acquisition, directly or indirectly, by any “person” or “persons” (as such terms are used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended), other than the Company or any employee benefit plan of the Company or an Affiliate, or any corporation pursuant to a reorganization, merger or consolidation of equity securities of the Company, resulting in such person or persons holding equity securities of the Company that, together with equity securities already held by such person or persons, in the aggregate
7
represent more than fifty percent (50%) of the total fair market value or total voting power of the Company’s then outstanding equity securities;
(c) individuals who as of the date hereof, constitute the Board (the “Incumbent Board”) cease for any reason to constitute at least a majority of the Board; provided, however, that any individual becoming a director subsequent to the date hereof whose election, or nomination for election by the Company’s shareholders, was approved by a vote of at least two-thirds of the directors then comprising the Incumbent Board shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a person other than the Board;
(d) a reorganization, merger or consolidation, with respect to which persons who were the holders of equity securities of the Company immediately prior to such reorganization, merger or consolidation, immediately thereafter, own equity securities of the surviving entity representing less than fifty percent (50%) of the combined ordinary voting power of the then outstanding voting securities of the surviving entity; or
(e) the acquisition within a twelve (12) month period, directly or indirectly, by any “person” or “persons” (as such terms are used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended), other than any corporation pursuant to a reorganization, merger or consolidation, of assets of the Company that have a total gross fair market value equal to or more than eighty-five percent (85%) of the total gross fair market value of all of the assets of the Company immediately before such acquisition.
Notwithstanding the foregoing, no Change in Control shall be deemed to have occurred for purposes of this Award (i) unless the event also constitutes a “change in the ownership or effective control of the corporation or in the ownership of a substantial portion of the assets of the corporation” within the meaning of Code Section 409A(a)(2)(v), or (ii) by reason of any actions or events in which the Recipient participates in a capacity other than in his capacity as an officer, employee, or director of the Company or an Affiliate.
“Common Stock” means common stock of the Company.
“Ending Stock Price” means the average closing price per share of Common Stock for the months of November and December 20__ on the exchange on which Common Stock is traded, unless a Change in Control occurs on or before December 31, 20__, in which case the term means the value per share determined as of the date of the Change in Control, such value to be determined by the Committee in its reasonable discretion based on the actual or implied price per share paid in the Change in Control transaction.
8
“Ending Value of Reinvested Dividends” means the dollar amount equal to the Ending Stock Price multiplied by the total number of shares hypothetically purchased with the dividends declared to a shareholder of record during the Performance Period, assuming that each dividend is re-invested in Common Stock at the closing price per share on the last business day before the ex-dividend date. For purposes of this calculation, the dividends declared to a shareholder of record during the Performance Period will initially be calculated on one share of Common Stock beginning as of the first dividend declaration date during the Performance Period, and as of each dividend declaration date during the Performance Period thereafter, the dividends will be calculated with respect to the sum of one share of Common Stock plus the cumulative number of shares of Common Stock hypothetically purchased prior to such dividend declaration date. The “Ending Value of Reinvested Dividends” can also be expressed as the following formula:
Ending Value of Reinvested Dividends = (Ending Stock Price x Total Number of Shares Hypothetically Purchased with Reinvested Dividends)
Total Number of Shares Hypothetically Purchased with Reinvested Dividends = Number of Shares Hypothetically Purchased with First Reinvested Dividend + the sum of the Number of Shares Hypothetically Purchased with each Subsequent Reinvested Dividend
Number of Shares Hypothetically Purchased with First Reinvested Dividend = (dividend declared to a shareholder of record during the Performance Period calculated on one share of Common Stock as of the first dividend declaration date during such period)/closing price per share of Common Stock on the last business day before the ex-dividend date)
Number of Shares Hypothetically Purchased with each Subsequent Reinvested Dividend = (each dividend declared to a shareholder of record after the first dividend declaration date during the Performance Period calculated on the sum of the one share of Common Stock beginning as of the first dividend declaration date + the number of shares hypothetically purchased with reinvested dividends before such subsequent dividend declaration date)/closing price per share of Common Stock on the last business day before the related ex-dividend date)
“Good Reason” shall have the meaning set forth in the employment agreement then in effect between the Recipient and the Company or an Affiliate, or, if there is none, then Good Reason shall mean the occurrence of an event listed in Subsection (a) through (c) below:
(a) the Recipient experiences a material diminution of the Recipient’s responsibilities of the Recipient’s position, as reasonably modified by the person to whom the Recipient reports or the Board from time to time, such that the Recipient would no longer have responsibilities substantially equivalent to those of other executives holding equivalent positions at companies with similar revenues and market capitalization;
9
(b) the Company or an Affiliate reduces the Recipient’s annual base salary or annual bonus opportunity at high, target or threshold performance as a percentage of annual base salary; or
(c) the Company or an Affiliate requires the Recipient to relocate the Recipient’s primary place of employment to a new location that is more than fifty (50) miles from its current location (determined using the most direct driving route), without the Recipient’s consent;
provided however, as to each event in Subsection (a) through (c),
(i) the Recipient gives written notice to the Company within ten (10) days following the event or receipt of notice of the event of the Recipient’s objection to the event;
(ii) the Company or the Affiliate which employs the Recipient fails to remedy the event within ten (10) days following the Recipient’s written notice; and
(iii) the Recipient terminates the Recipient’s employment within thirty (30) days following the Company’s and the Affiliate’s failure to remedy the event.
“High Relative TSR” means that Relative Total Shareholder Return is ____ basis points or more.
“Limited Partnership Agreement” means the Second Amended and Restated Agreement of OHI Healthcare Properties Limited Partnership, dated as of April 1, 2015, as it may be amended or any successor agreement thereto.
“Performance Period” means the period from and including January 1, 20__ through the earlier of December 31, 20__ or the date of a Change in Control.
“Relative Total Shareholder Return” means the Company’s total shareholder return expressed as a positive or negative number of basis points relative to the average total shareholder return reported for the FTSE NAREIT Equity Health Care Index (the “Index”) for the Performance Period. For this purpose, the Company’s total shareholder return shall be calculated in the same manner as total shareholder return is calculated for the Index, and the average closing price per share for the November and December before the beginning, and at the end, of the Performance Period shall be used for calculating both the Company’s total shareholder return and total shareholder return for the Index.
“Target Relative TSR” means that Relative Total Shareholder Return is ___ basis points.
“Threshold Relative TSR” means that Relative Total Shareholder Return is ____ basis points.
10
“Total Shareholder Return” means the compound annual growth rate (also known as “CAGR”), expressed as a percentage, of an investment in one share of Common Stock over the Performance Period, based on the Ending Stock Price plus the Ending Value of Reinvested Dividends, as compared to the Beginning Stock Price, and using the following formula:
(((Ending Stock Price + Ending Value of Reinvested Dividends)/Beginning Stock Price)^(1/3)) – 1
“Vesting Period” means the period beginning on the day after the last day of the Performance Period and ending December 31, 20__.
11
EXHIBIT 1
A. Except as provided in Items B and C below, the number of Unvested Profits Interest Units that is earned (the “Earned Unvested Profits Interest Units”) is determined as of the last day of the Performance Period from the Relative TSR Chart set forth below, provided that the Recipient shall vest in twenty-five percent (25%) of the Earned Unvested Profits Interest Units, which shall then become Vested Profits Interest Units, as of the last day of each calendar quarter during the Vesting Period only if the Recipient remains an employee, director or consultant of the Company or an Affiliate during the entire Performance Period and through the last day of such calendar quarter.
Relative TSR Chart
Below |
*Threshold |
*Target |
*High |
Zero |
|
|
|
* If Total Shareholder Return falls between Threshold Relative TSR and Target Relative TSR or between Target Relative TSR and High Relative TSR, the number of Earned Unvested Profits Interest Units under the Relative TSR Chart shall be determined in accordance with a separate written interpolation methodology established by the Company in connection with valuing the Profits Interest Units as of the Grant Date.
B. Except as provided in Item C below, if the Recipient dies or becomes subject to a Disability while an employee, director or consultant of the Company or an Affiliate, the Recipient resigns from the Company and all Affiliates for Good Reason or the Company and all Affiliates terminate the Recipient’s employment without Cause (each such event referred to as a “Qualifying Termination”), in each case:
(i) during the Performance Period, the Recipient shall vest upon completion of the Performance Period in the number of Earned Unvested Profits Interest Units determined from the Relative TSR Chart (or if a Change in Control occurs after the Qualifying Termination and on or before December 31, 20__, the number of Earned Unvested Profits Interest Units determined pursuant to Section C.1. below), multiplied by a fraction, the numerator of which is the number of days elapsed in the Performance Period through the date of such event and the denominator of which is 1,095 (i.e., 365 x 3), or
(ii) during the Vesting Period, the Recipient shall vest in the same number of Earned Unvested LTIP Units determined in the Relative TSR Chart as if the Recipient were to remain an employee of the Company or an Affiliate through the last day of the Vesting Period.
C. Notwithstanding Item C above, if a Change in Control occurs upon or after the Grant Date and on or before December 31, 20__, and (i) the Recipient remains an employee, director or consultant of the Company or an Affiliate during the entire Performance Period until the date of the Change in Control, or (ii) if within sixty (60) days before the Change in Control, the Recipient incurs a Qualifying Termination, the Recipient shall be 100% vested in, as of the date of the Change in Control:
1. if the Change in Control occurs on or before December 31, 20__, the number of Earned Unvested Profits Interest Units determined from the Relative TSR Chart based on the basis points of Relative Total Shareholder Return achieved for the Performance Period through the date of the Change in Control, or
2. if the Change in Control occurs after December 31, 20__, the number of Earned Unvested Profits Interest Units determined in the Relative TSR Chart that were actually earned for the Performance Period which have not previously become Vested Stock Units pursuant to Item B (i) above.
D. All Profits Interest Units that have not become Earned Unvested Profits Interest Units as of the last day of the Performance Period shall be forfeited as of the last day of the Performance Period. All Unvested Profits Interest Units that have not become Vested Profits Interest Units (except Earned Unvested Profits Interest Units to the extent provided in Item B or C) as of the date the Recipient ceases to be an employee, director, or consultant of the Company and all Affiliates shall be forfeited.
E. If any calculation in this Exhibit results in a fractional number of Vested Profits Interest Units, the number of Vested Profits Interest Units shall be rounded to the closest whole number.
2
EXHIBIT 2
Representations and Warranties of the Recipient
In connection with the grant of the Profits Interest Units pursuant to the Agreement, the Recipient hereby represents and warrants to the Partnership that:
1. The Recipient is acquiring the Profits Interest Units for the Recipient’s own account with the present intention of holding the Profits Interest Units for investment purposes and not with a view to distribute or sell the Profits Interest Units, except in compliance with federal securities laws or applicable securities laws of other jurisdictions;
2. The Recipient acknowledges that the Profits Interest Units have not been registered under the Securities Act of 1933 (the “1933 Act”) or applicable securities laws of other jurisdictions and that the Profits Interest Units will be issued to the Recipient in reliance on exemptions from the registration requirements provided by Sections 3(b) or 4(2) of the 1933 Act and the rules and regulations promulgated thereunder and applicable securities laws of other jurisdictions and in reliance on the Recipient’s representations and agreements contained herein;
3. The Recipient is an employee of the Partnership or an Affiliate;
4. The Recipient acknowledges that the Profits Interest Units are subject to the restrictions contained in the Limited Partnership Agreement, and the Recipient has received and reviewed a copy of the Limited Partnership Agreement;
5. The Recipient has had the opportunity to ask questions of and receive answers from the Partnership and any person acting on its behalf concerning the terms and conditions of the Profits Interest Units awarded hereunder and has had full access to such other information concerning the Partnership and its Affiliates as the Recipient may have requested in making the Recipient’s decision to invest in the Profits Interest Units being issued hereunder;
6. The Recipient has such knowledge and experience in financial and business matters that the Recipient is capable of evaluating the merits and risks of the acquisition of the Profits Interest Units hereunder and the Recipient is able to bear the economic risk, if any, of such acquisition;
7. The Recipient has only relied on the advice of, or has consulted with, the Recipient’s own legal, financial and tax advisors, and the determination of the Recipient to acquire the Profits Interest Units pursuant to this Agreement has been made by the Recipient independent of any statements or opinions as to the advisability of such acquisition or as to the properties, business, prospects or condition (financial or otherwise) of the Partnership or its Affiliates which may have been made or given by any other person or by any agent or employee of such person and independent of the fact that any other person has decided to become a holder of Profits Interest Units;
8. None of the Partnership or any of its Affiliates has made any representation or agreement to the Recipient with respect to the income tax consequences of the issuance,
ownership or vesting of Profits Interest Units or the transactions contemplated by this Agreement (including without limitation the making of an election under Code Section 83(b)), and the Recipient is in no manner relying on the Partnership or any Affiliate or their representatives for an assessment of tax consequences to the Recipient. The Recipient is advised to consult with the Recipient’s own tax advisor with respect to the tax consequences;
9. The Recipient is not acquiring the Profits Interest Units as a result of, or subsequent to, any publicly disseminated advertisement, article, sales literature, publication, broadcast or any public seminar or meeting or any solicitation nor is the Recipient aware of any offers made to other persons by such means;
10. The Recipient understands and agrees that if certificates representing the Profits Interest Units are issued, such certificates may bear such restrictive legends as the Partnership or its legal counsel may deem necessary or advisable under applicable law or pursuant to this Agreement;
11. The Profits Interest Units cannot be offered for sale, sold or transferred by the Recipient other than pursuant to: (i) an effective registration under the 1933 Act or in a transaction otherwise in compliance with the 1933 Act; and (ii) evidence satisfactory to the Partnership of compliance with the applicable securities laws of other jurisdictions. The Partnership shall be entitled to rely upon an opinion of counsel satisfactory to it with respect to compliance with the above laws;
12. The Partnership shall be under no obligation to register the Profits Interest Units or to comply with any exemption available for sale of the Profits Interest Units without registration or filing;
13. The Recipient represents that the Recipient is an “accredited investor” as that term is defined in Rule 501 of Regulation D of the 33 Act; specifically, either (a) the Recipient is an executive officer of the Partnership or of Omega Healthcare Investors, the general partner of the Partnership, or (b) the Recipient has (i) had an individual income in excess of $200,000 in each of the two most recent years or joint income with the Recipient’s spouse in excess of $300,000 in each of those years and has a reasonable expectation of reaching the same income level in the current year, or (ii) the Recipient’s net worth or joint net worth with the Recipient’s spouse (excluding the value of the Recipient’s primary residence), exceeds $1,000,000; and
14. The Recipient agrees to furnish any additional information requested to assure compliance with applicable securities laws in connection with the issuance or holding of Profits Interest Units. The Recipient acknowledges that the Plan and this Agreement are intended to conform to the extent necessary with applicable federal and state laws. Notwithstanding anything to the contrary herein, the Plan shall be administered and the grant of Profits Interest Units is made only in such manner as to conform to such laws. To the extent permitted by applicable law, the Plan and this Agreement shall be deemed amended to the extent necessary to conform to such laws. By execution below, the Recipient acknowledges that he has received a copy of the Agreement, the Limited Partnership Agreement and the Plan.
2
RECIPIENT
Signature |
Date |
|
Name |
3
EXHIBIT 3
SECTION 83(b) ELECTION
The undersigned hereby elects to be taxed pursuant to Section 83(b) of the Internal Revenue Code of 1986 (the “Code”) with respect to the property described below and supplies the following information in accordance with the regulations promulgated thereunder:
1. The name, address and taxpayer identification number of the undersigned is:
________________________
________________________
________________________
Taxpayer I.D. No.: ________________________
2. Description of property with respect to which the election is being made:
_______ Profits Interest Units of OHI Healthcare Properties Limited Partnership (the “Profits Interest Units,” defined in the OHI Healthcare Properties Limited Partnership as “LTIP Units”).
3. The date on which the property was transferred:
The Profits Interest Units were transferred on January 1, 20__.
4. The taxable year to which this election relates is calendar year 20__.
5. The nature of the restriction(s) to which the property is subject is:
The Profits Interest Units shall vest in increments on specified vesting dates or upon certain vesting events subsequent to the property transfer date, provided that the taxpayer continues to perform services for OHI Healthcare Properties Limited Partnership (the “Partnership”) or an affiliate. In the event the taxpayer ceases to perform services for the Partnership and its affiliates prior to the final vesting date, any unvested Profits Interest Units shall be forfeited back to the Partnership.
6. Fair Market Value:
Because the Profits Interest Units constitute a profits interest, the grant of the interest is not taxable under Code Section 83 pursuant to Revenue Procedure 93-27 and Revenue Procedure 2001-43. Therefore, the taxpayer is reporting that the fair market value at the time of transfer (determined without regard to any restrictions other than restrictions which by their terms will never lapse) of the property with respect to which this election is being made as $0 per Profits Interest Unit.
7. Amount paid for property:
The taxpayer did not pay for the Profits Interest Units.
8. Furnishing statement to the person for whom services are performed:
A copy of this statement has been furnished to the Partnership.
By: |
|
|
Date: |
|
This ‘10-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 2/26/19 | |||
For Period end: | 12/31/18 | 4 | ||
4/1/15 | 3, 4, 4/A | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/14/23 Omega Healthcare Investors Inc. 10-K 12/31/22 150:30M 2/17/22 Omega Healthcare Investors Inc. 10-K 12/31/21 155:28M 2/22/21 Omega Healthcare Investors Inc. 10-K 12/31/20 142:28M |